Dendrite has launched a new CRM web portal, Patient-Connect.
US pharmaceutical technology firm Dendrite has launched a new customer relationship management (CRM) and disease management web portal, Patient-Connect. By sponsoring the website, pharmaceutical companies will have the opportunity to interact with an increasing online population that suffers from chronic medical conditions.
The disease management portal will allow patients to monitor and manage their conditions through online features such as interactive disease tracking tools, automatic prescription refill and renewal reminders, support groups, secure messaging, educational resources and daily news and information feeds.
There are numerous benefits for pharmaceutical companies of adopting online compliance and disease management tools. Companies generally focus on increasing patient loyalty to particular brands or brand lines while offering companies the opportunity to cultivate longer-term relationships with patients, thus gaining valuable insight into patient needs and satisfaction levels. This understanding of the patient is a central feature of any successful pharmaceutical customer relationship management strategy.
However, the greatest benefit of using a service such as Patient-Connect is the ability of companies to track prescription sales immediately, therefore allowing them to apply return on investment metrics to measure success. As more patients become comfortable with using online disease management tools and become aware of the value such services can offer, the return on investment of disease management and pharmaceutical customer relationship management strategies will improve.
